151 related articles for article (PubMed ID: 31541468)
1. miR-122-5p promotes aggression and epithelial-mesenchymal transition in triple-negative breast cancer by suppressing charged multivesicular body protein 3 through mitogen-activated protein kinase signaling.
Wang Z; Wang X
J Cell Physiol; 2020 Mar; 235(3):2825-2835. PubMed ID: 31541468
[TBL] [Abstract][Full Text] [Related]
2. Unleashing Breast Cancer Progression: miR-455-5p's Targeting of SOCS3 Drives Proliferation, Migration, and Invasion.
Li X; Peng B; Li J; Tian M; He L
Protein Pept Lett; 2023; 30(12):992-1000. PubMed ID: 38013437
[TBL] [Abstract][Full Text] [Related]
3. Shikonin inhibits migration and invasion of triple-negative breast cancer cells by suppressing epithelial-mesenchymal transition via miR-17-5p/PTEN/Akt pathway.
Bao C; Liu T; Qian L; Xiao C; Zhou X; Ai H; Wang J; Fan W; Pan J
J Cancer; 2021; 12(1):76-88. PubMed ID: 33391404
[No Abstract] [Full Text] [Related]
4. Long noncoding RNA LINC00885 upregulates NCK1 to promote cell viability and migration of triple-negative breast cancer cells through sponging miR-654-3p.
He P; Liu Z; Qi J; Shan J; Sheng J
Cancer Biomark; 2024; 39(1):63-78. PubMed ID: 37694355
[TBL] [Abstract][Full Text] [Related]
5. lncRNA SEMA3B-AS1 Inhibits miR-513c-5p to Regulate the Progression of Triple-negative Breast Cancer.
Yu H; Wu Y; Huang J; Li S
Anticancer Res; 2023 Dec; 43(12):5475-5484. PubMed ID: 38030196
[TBL] [Abstract][Full Text] [Related]
6. miR-655 suppresses epithelial-to-mesenchymal transition by targeting Prrx1 in triple-negative breast cancer.
Lv ZD; Kong B; Liu XP; Jin LY; Dong Q; Li FN; Wang HB
J Cell Mol Med; 2016 May; 20(5):864-73. PubMed ID: 26820102
[TBL] [Abstract][Full Text] [Related]
7. miR-720 is a downstream target of an ADAM8-induced ERK signaling cascade that promotes the migratory and invasive phenotype of triple-negative breast cancer cells.
Das SG; Romagnoli M; Mineva ND; Barillé-Nion S; Jézéquel P; Campone M; Sonenshein GE
Breast Cancer Res; 2016 Apr; 18(1):40. PubMed ID: 27039296
[TBL] [Abstract][Full Text] [Related]
8. Oncogenic miR-106b-5p promotes cisplatin resistance in triple-negative breast cancer by targeting GDF11.
Zhou Q; Hu Q
Histol Histopathol; 2024 Apr; 39(4):533-541. PubMed ID: 37905957
[TBL] [Abstract][Full Text] [Related]
9. PKMYT1 Promotes Epithelial-Mesenchymal Transition Process in Triple-Negative Breast Cancer by Activating Notch Signaling.
Li B; Huang L; Ruan J
Rev Invest Clin; 2024; 76(1):45-59. PubMed ID: 38442372
[TBL] [Abstract][Full Text] [Related]
10. Silencing of Prrx1b suppresses cellular proliferation, migration, invasion and epithelial-mesenchymal transition in triple-negative breast cancer.
Lv ZD; Yang ZC; Liu XP; Jin LY; Dong Q; Qu HL; Li FN; Kong B; Sun J; Zhao JJ; Wang HB
J Cell Mol Med; 2016 Sep; 20(9):1640-50. PubMed ID: 27027510
[TBL] [Abstract][Full Text] [Related]
11. MiR-4649-5p acts as a tumor-suppressive microRNA in triple negative breast cancer by direct interaction with PIP5K1C, thereby potentiating growth-inhibitory effects of the AKT inhibitor capivasertib.
Jonas K; Prinz F; Ferracin M; Krajina K; Pasculli B; Deutsch A; Madl T; Rinner B; Slaby O; Klec C; Pichler M
Breast Cancer Res; 2023 Oct; 25(1):119. PubMed ID: 37803350
[TBL] [Abstract][Full Text] [Related]
12. MiR-191-5p inhibits KLF6 to promote epithelial-mesenchymal transition in breast cancer.
Pan L; Liu W; Zhao H; Chen B; Yue X
Technol Health Care; 2023; 31(6):2251-2265. PubMed ID: 37545272
[TBL] [Abstract][Full Text] [Related]
13. MiR-99a-5p Constrains Epithelial-Mesenchymal Transition of Cervical Squamous Cell Carcinoma Via Targeting CDC25A/IL6.
Gu A; Bao X
Mol Biotechnol; 2022 Nov; 64(11):1234-1243. PubMed ID: 35532870
[TBL] [Abstract][Full Text] [Related]
14. Extracellular matrix marker LAMC2 targets ZEB1 to promote TNBC malignancy via up-regulating CD44/STAT3 signaling pathway.
Wang D; Keyoumu K; Yu R; Wen D; Jiang H; Liu X; Di X; Zhang S
Mol Med; 2024 May; 30(1):61. PubMed ID: 38760717
[TBL] [Abstract][Full Text] [Related]
15. miR-524-5p suppresses the growth of oncogenic BRAF melanoma by targeting BRAF and ERK2.
Liu SM; Lu J; Lee HC; Chung FH; Ma N
Oncotarget; 2014 Oct; 5(19):9444-59. PubMed ID: 25275294
[TBL] [Abstract][Full Text] [Related]
16. Mesenchymal stem cell-derived exosomes enriched with miR-218 reduce the epithelial-mesenchymal transition and angiogenesis in triple-negative breast cancer cells.
Shojaei S; Moradi-Chaleshtori M; Paryan M; Koochaki A; Sharifi K; Mohammadi-Yeganeh S
Eur J Med Res; 2023 Nov; 28(1):516. PubMed ID: 37968694
[TBL] [Abstract][Full Text] [Related]
17. CLPs-miR-103a-2-5p inhibits proliferation and promotes cell apoptosis in AML cells by targeting LILRB3 and Nrf2/HO-1 axis, regulating CD8 + T cell response.
Cen Q; Chen J; Guo J; Chen M; Wang H; Wu S; Zhang H; Xie X; Li Y
J Transl Med; 2024 Mar; 22(1):278. PubMed ID: 38486250
[TBL] [Abstract][Full Text] [Related]
18. Long-chain noncoding RNA LINC01569 upregulates filamin A-interacting protein 1-like to prevent metastasis of triple-negative breast cancer via sponging miR-300.
Jiang X; Lin J; Zhu Z
Cancer Biomark; 2024; 39(2):79-94. PubMed ID: 37955081
[TBL] [Abstract][Full Text] [Related]
19. Demethylase FTO inhibits the occurrence and development of triple-negative breast cancer by blocking m
Ni J; Lu X; Gao X; Jin C; Mao J
Acta Biochim Biophys Sin (Shanghai); 2024 Jan; 56(1):114-128. PubMed ID: 38151999
[TBL] [Abstract][Full Text] [Related]
20. CHMP3 promotes the progression of hepatocellular carcinoma by inhibiting caspase‑1‑dependent pyroptosis.
Zheng Y; Yang S; Dai W; Wang J; Bi S; Zhang X; Zheng Z; Sun Y; Wu S; Kong J
Int J Oncol; 2024 Jan; 64(1):. PubMed ID: 38038147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
